Exploring the stability of risk preference: Meta-analysis reveals discrepancies in how it’s measured

Past psychology research suggests that some people are more prone than others to take risks in uncertain situations, such as investing money in risky business ventures, consuming addictive substances or leaving a secure job without any sure alternative prospects. Over the past decades, psychologists and behavioral scientists have been trying to understand the extent to which people’s willingness to take risks (i.e., risk preference) is stable and coherent, which means that it tends to remain consistent over time and across different contexts.

The link between headache disorders and suicide—a 25-year Danish cohort study

New evidence from a large population-based cohort analysis indicates an increased risk of both attempted and completed suicide among individuals diagnosed with headache disorders. Researchers at Aarhus University in Denmark found that individuals diagnosed with migraine, tension-type headache, posttraumatic headache, and trigeminal autonomic cephalalgia face an increased risk of suicide.

Clot-busting meds may be effective up to 24 hours after initial stroke symptoms

The clot-dissolving medication, alteplase, improved stroke patients’ recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary late-breaking science presented today at the American Stroke Association’s International Stroke Conference 2025. The conference, in Los Angeles, Feb. 5-7, 2025, is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.